COVID-19 and the impact on gynecologic cancer care.
Int J Gynaecol Obstet
; 155 Suppl 1: 94-101, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-1575396
ABSTRACT
The COVID-19 pandemic resulted in significant reconfiguration of gynecologic cancer services and care pathways across the globe, with a transformation of working practices. Services had to adapt to protect their vulnerable patients from infection, whilst providing care despite reduced resources/capacity and staffing. The international gynecologic cancer community introduced modified clinical care guidelines. Remote working, reduced hospital visiting, routine COVID-testing, and use of COVID-free surgical areas/hubs enabled the ongoing and safe delivery of complex cancer care, with priority levels for cancer treatments established to guide decision-making by multidisciplinary tumor boards. Some 2.3 million cancer surgeries were delayed or cancelled during the first peak, with many patients reporting significant anxiety/concern for cancer progression and COVID infection. Although COVID trials were prioritized, recruitment to other cancer trials/research activity was significantly reduced. The impact of resultant protocol deviations on outcomes remains to be established. During the recovery healthcare services must maintain capacity and flexibility to manage future surges of infection, address the large backlog of patients with altered or delayed treatments, along with salvaging screening and prevention services. Training needs/mental well-being of trainees need addressing and staff burnout prevented. Future research needs to fully evaluate the impact of COVID-19 on long-term patient outcomes.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Genital Neoplasms, Female
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Female
/
Humans
Language:
English
Journal:
Int J Gynaecol Obstet
Year:
2021
Document Type:
Article
Affiliation country:
Ijgo.13868
Similar
MEDLINE
...
LILACS
LIS